Genpact stock reaction and recent performance snapshot

Genpact (G) has attracted fresh attention after recent trading left the shares about 25% lower year to date, with a decline of roughly 30% over the past year and about 22% over the past 3 months.

At a share price of $34.33, Genpact’s recent 30 day share price return of 9% and 90 day share price return of 22% point to fading momentum that aligns with a 1 year total shareholder return of 30% and weaker multi year results.

If Genpact’s pullback has you reassessing the sector, it could be a useful moment to broaden your search and check out 17 top founder-led companies

So with Genpact trading at $34.33, a value score of 6, and estimates implying a sizeable discount to some analyst targets and intrinsic value, are you looking at a genuine opportunity or a stock where future growth is already priced in?

Most Popular Narrative: 28.7% Undervalued

With Genpact last closing at $34.33 against a narrative fair value of $48.18, the most followed storyline around the stock points to a sizeable valuation gap built on expectations of higher margin, AI driven services and ongoing returns of capital to shareholders.

Accelerated client adoption of Genpact's Advanced Technology Solutions, particularly in data and AI, should drive higher growth and improved margins, as these offerings deliver over twice the revenue per headcount versus legacy services and are expanding at over twice the company's overall rate, pointing toward robust long-term revenue and margin expansion.

Want to see what underpins that premium AI and data push, and how it connects to future revenue, margins and earnings power? The core assumptions behind this fair value are all laid out in one place, including how profitability, growth and valuation multiples are expected to interact over the coming years.

Result: Fair Value of $48.18 (UNDERVALUED)

However, the story can change quickly if legacy BPO weakness deepens or large AI and digital deals take longer to materialise, affecting the revenue mix and margins.

Next Steps

If the mixed messages around Genpact’s valuation and growth drivers leave you unsure, this is the moment to move fast and test the story against the numbers yourself. Start by weighing the upside factors that others are focusing on through 5 key rewards

Looking for more investment ideas?

If Genpact has sharpened your thinking, do not stop here. The next strong addition to your portfolio could be one smart screen away.

• Zero in on quality at a discount by scanning 51 high quality undervalued stocks that meet your standards on fundamentals and price.
• Strengthen your income stream by reviewing 13 dividend fortresses that aim to pair higher yields with resilient cash flows.
• Stay ahead of the crowd by checking the screener containing 25 high quality undiscovered gems before other investors turn their attention there.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.